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Cardiopulmonary b pass was established by bicaval cannu- 
lation and common femoral arterial return. A parallel 0.25- 
inch cannula was connected between the arterial return and 
the SVC cannula by means of Y connectors to provide RCP 
after HCA. This was primed and clamped at both ends. 
After implementation f HCA (nasopharyngeal tempera- 
ture 15 ° C), the femoral arterial cannula was clamped and 
the blood was drained into the cardiotomy reservoir. The 
SVC cannula was isolated from the venous circulation, and 
RCP commenced with flow (mean 383 _+ 35 ml/min) ad- 
justed to maintain a right jugular bulb pressure of 25 mm Hg 
or less. A dedicated retrograde right internal jugular line 
independent of any drug infusions was used to measure 
jugular bulb pressure. A detailed description of our RCP 
circuit can be found elsewhere. 3 
Before circulatory arrest, a portable gamma camera 
(Siemens LEM+; Siemens AG, Erlangen, Germany) 
linked to a dedicated nuclear medicine computer system 
(Gamma 11, Nuclear Diagnostics, Kent, United King- 
dom) was placed anterior to the head of the patient. After 
HCA and immediately before the commencement of
RCP, 100 MBq of 99mTc-HMPAO was administered into 
the cardiotomy reservoir and allowed to diffuse. Planar 
dynamic brain imaging was commenced when the first sign 
of activity was seen in the SVC. Images were acquired 
every 2 seconds for the first 2 minutes and every minute 
thereafter for the duration of RCP (mean 32 _+ 7 min- 
utes). Inspection of the gamma camera images showed 
99mTc-HMPAO activity spreading quickly from the right 
jugular bulb through the cerebral vascular tree (Fig. 1) 
and throughout he brain within 3 minutes (Fig. 2). 
Continuous 99mTc-HMPAO accumulation was seen in the 
gray and white matter for the duration of RCP, with 
reduction of activity in the superior sagittal sinus as the 
agent was cleared from the blood pool. Time activity 
curves constructed for both cerebral hemispheres and a 
background region in the neck demonstrate homogeneous 
perfusion in both cerebral hemispheres (Fig. 3). 
One of the patients, who had previously undergone a
repeated aortic valve replacement and coronary artery 
revascularization a d had dissecting type A aortic aneu- 
rysm and vein graft occlusion, died of myocardial failure 
in the early postoperative period. Assessment of neuro- 
logic function was not possible because the patient was 
electively sedated uring the postoperative course. The 
remaining two patients had normal return to conscious- 
ness in less then 24 hours after operation and had no 
neurologic omplications. 
This pilot study demonstrates that cerebral perfusion 
does occur with RCP in human beings. The question of 
whether the metabolic demands of the brain may be met 
with this technique remains to be answered. 
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RETRANSFUSION OF THORACIC WOUND BLOOD DURING HEART SURGERY OBSCURES 
BIOCOMPATIBILITY OF THE EXTRACORPOREAL CIRCUIT 
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and Tjark Ebels, MD, PhD, b Groningen, The Netherlands 
To minimize blood trauma and postoperative patho- 
logic outcomes, it is of great concern to improve the 
biocompatibility of extracorporeal circuits. 1 Worldwide, 
many comparative studies have been performed to select 
the most biocompatible extracorporeal circuit. In many of 
these studies, however, a systematic error was made. 
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Retransfusion of heparinized blood from the wound area 
is an established method to attenuate excessive blood loss 
during cardiopulmonary b pass (CPB). Retransfusion of 
this wound blood is feasible by suction from the thoracic 
cavity and recirculation through the cardiotomy reservoir. 
Because wound blood is highly traumatized, as we dem- 
onstrated in recent studies, 2'3 there are likely to be 
significant effects of wound blood retransfusion on the 
systemic blood, depending on the amount of retransfused 
wound blood. Particularly, retransfusion of the damaged 
wound blood could obscure possible improvements in 
biocompatibility of extracorporeal circuits. 4 In this study, 
wound blood was retained uring CPB in one group of 14 
patients and retransfused only at the end of bypass. The 
control group consisted of 20 other patients, who were 
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Fig. 1. The degree of hemolysis during CPB is reflected by plasma levels of hemoglobin (Free Plasma Hb). 
Mean values of the patient group with continuous retransfusion ofwound blood are indicated by the white 
bars; rnean values of the patient group with retainment of wound blood are indicated by gray bars. The 
sample points indicate 5 minutes after heparinization and before start of CPB (-5'), before release of the 
aortic crossclamp @re-X), after release of the aortic crossclamp (post-X), and at the end of CPB (end CPB). 
The wound blood bar indicates the concentration of free hemoglobin i  the wound blood during retention. 
Error bars indicate the standard error of the mean. An asterisk indicates a significant difference (p < 0.01 
by unpaired Student's t test) between both groups at a specific sample point. 
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Fig. 2. The degree of clotting activation during CPB is reflected by plasma levels of TAT III (TAT). All 
other graph specifications are the same as those in Fig. 1. 
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Fig. 3. The degree of platelet degranulation during CPB is reflected by plasma levels of/3-TG. All other 
graph specifications are the same as those in Fig. 1. 
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Fig. 4. The degree of complement activation during CPB is reflected by plasma levels of complement 
factor C3adesA,g (C3a). All other graph specifications are the same as those in Fig. 1. 
subjected to immediate and continuous retransfusion of 
wound blood during the operation. Blood damage and 
activation during operation were assessed by measuring 
the plasma levels of variables indicative of hemolysis (Fig. 
1), clotting (Fig. 2), platelet degranulation (Fig. 3), and 
complement activation (Fig. 4). The validity of these 
variables in reflecting extracorporeal related blood dam- 
age could thus be evaluated. 
None of the patients ubjected to elective CPB received 
any drugs known to affect the clotting system or platelets 
during the last 7 days before the CPB bypass procedure. 
All circuits were primed with 2000 ml of oxypolygelatin 
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(Gelifundol; Biotest Pharma GmbH, Dreiech, Germany) 
and 1500 IU of bovine heparin (Leo, Emmen, The 
Netherlands). Heparinization was achieved by introduc- 
tion of 300 IU/kg heparin intravenously, with additional 
heparin if the activated clotting time fell under 400 
seconds. Samples for biochemical assays were taken 5 
minutes after heparinization (and before start of CPB), 
just before release of the aortic crossclamp, immediately 
after release of the aortic crossclamp, and at the end of 
bypass (after t]he retransfusion of the wound blood in the 
retainment group). In 14 patients, the wound blood was 
sucked into a separate container connected to the cardiot- 
omy reservoir and retained uring the surgical procedure. 
Before retransfusion of this blood at the end of CPB, the 
retained wound blood was also sampled. Hemolysis was 
determined by measuring levels of free plasma hemoglo- 
bin by a spectrophotometric e hnique 5 (Fig. 1). Clotting 
activation was reflected by plasma levels of thrombin- 
antithrombin III complex (TAT III, Fig. 2), determined by 
enzyme-linked immunosorbent assay (Behring, Marburg, 
Germany); platelet degranulation was reflected by plasma 
levels /3-thromboglobulin (/3-TG; Fig. 3), determined by 
radioimmunoassay (Kodak, Amersham, U.K.). Comple- 
ment activation was reflected by plasma levels C3adesArg 
(Fig. 4), determined by enzyme-linked immunosorbent 
assay (Quidel, San Diego, Calif.). Because of the hemodi- 
lution by admJxture of prime solution from the extracor- 
poreal circuit, all obtained ata were corrected for hema- 
tocrit before further evaluation. 
The effect of retransfusing wound blood on circulating 
concentrations of products uch as free hemoglobin and 
TAT III was demonstrated by the immediate increase in 
the blood retention group after the retransfusion and the 
more gradual and lesser increase in patients with contin- 
uous retransfusion. Furthermore, the lack of any notice- 
able increase of these variables before retransfusion en- 
dorses the dominating effect of wound blood retransfusion 
on free hemog][obin and TAT III levels. Moreover, the high 
concentrations of free hemoglobin and TAT III in the 
wound blood explain the observed increases atisfactorily. 
Concentrations of /3-TG also increased, in particular 
after the retransfusion of wound blood. A significant 
increase of jB-TG in the retainment group was also 
observed, however, during the first phase of CPB before 
release of the aortic crossclamp and before any retransfu- 
sion of wound blood. This increase, independent of re- 
transfusion, strongly suggests that the extracorporeal cir- 
cuit contributes ignificantly to platelet damage. Finally, 
the complement system was activated in both groups of 
patients, as indicated by the increasing C3a concentrations 
after the start of CPB, although to a rauch lesser extent in 
the blood retention group than in patients who underwent 
continuous retransfusion. The common C3a generation 
indicates complement activation by the extracorporeal 
circuit in a!l patients. ó The differences between groups is 
explainable by the method of wound blood retransfusion. 
It is likely that blood complement in the wound is 
activated through the classic pathway, resulting in C3a 
levels similar 1:o the levels in circulation. The increase in 
systemic C3a level after continuous retransfusion or re- 
transfusion of retained wound blood suggests that infusion 
of denatured or substances unfamiliar to blood is trigger- 
ing an additional systemic complement activation re- 
sponse. 7 
In conclusion, our study demonstrates that data ob- 
tained in previous clinical studies that focused on biocom- 
patibility assessment of extracorporeal circuits were bi- 
ased when substantial amounts of wound blood were 
retransfused uring the procedure. Blood activation re- 
lated to clotting, platelet degranulation, complement ae- 
tivation, and hemolysis by the extracorporeal circuit dur- 
ing CPB--as indicated by TAT III, fI-TG, C3a, and free 
hemoglobin--is vastly influenced by the retransfusion of 
wound blood. Moreover, free hemoglobin and TAT III 
generation related to the extracorporeal circuit were 
found insignificant. Variables uch as TAT III and hemo- 
lysis are therefore unfit to analyze and quantify the 
biocompatibility of extracorporeal circuits. Furthermore, 
biocompatibility of extracorporeal circuits, as analyzed 
by variables uch as C3a and/3-TG, cannot be evaluated 
with the presently used technique for heart operations 
of Continuously retransfusing wound blood. We suggest 
that the wound blood be retained uring assessment of the 
biocompatibility of extracorporeal circuits or that the 
wound blood be washed by cell-saving techniques, to 
wash out the disturbing plasma factors before retrans- 
fusion. 
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